𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Asymmetric corticomotor excitability correlations in early Parkinson's disease

✍ Scribed by Allan D. Wu; Giselle M. Petzinger; Chien-Ho J. Lin; Myron Kung; Beth Fisher


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
120 KB
Volume
22
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We studied corticomotor excitability (CE) between the more and less affected sides in early Parkinson's disease (PD) patients using transcranial magnetic stimulation (TMS). Sixteen‐PD patients within the first 3 years of diagnosis were studied with single‐pulse TMS over each motor cortex with intensities from 40% to 100% stimulator output. Active motor evoked potentials (MEP) and cortical silent period durations (CSP) were recorded, fitted with sigmoid curves, summarized as maximal MEP/CSP, maximal MEP/CSP slope, and intensity where MEP/CSP is half‐maximal (MEP/CSP‐Int50), and correlated with Unified Parkinson's Disease Rating Scale scores (UPDRS). On the more affected side, higher (worse) UPDRS scores were correlated with shorter maximal CSP (r = −0.51, P = 0.046). On the less affected side, higher UPDRS scores were correlated with higher MEP‐Int50 (r = 0.51, P = 0.043) and CSP‐Int50 (r = 0.54, P = 0.029). For the less affected side, altered CE, as indexed by higher MEP or CSP‐Int50 intensities, may contribute to early clinical symptoms. On the more affected side, increases in CE, indexed by shorter CSP, may account for a greater proportion of PD symptoms. These findings are consistent with an evolution of neurophysiologic correlates in early PD patients from a less to more symptomatic state. © 2007 Movement Disorder Society


📜 SIMILAR VOLUMES


Levodopa response in early Parkinson's d
✍ Robert A. Hauser; Peggy Auinger; David Oakes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks

Muscle strength in early Parkinson's dis
✍ Hiroshi Nogaki; Toshihiro Fukusako; Fujio Sasabe; Kiyoshi Negoro; Mitsunori Mori 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB
Speech dysfunction in early Parkinson's
✍ Dr. Celia Stewart; Linda Winfield; Ann Hunt; Susan B. Bressman; Stanley Fahn; An 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 1 views

## Abstract The purpose of this study is to determine if subjects in the early stages of untreated Parkinson's disease (PD) or PD treated with deprenyl alone suffer from motor speech abnormalities. Speech defects are common in advanced PD, including distrubances of respiration, phonation, and artic

Cognitive decline in early Parkinson's d
✍ Nagaendran Kandiah; Kaavya Narasimhalu; Puay-Ngoh Lau; Soo-Hoon Seah; Wing Lok A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

## Abstract Data on the prevalence and severity of cognitive impairment among patients with newly diagnosed idiopathic Parkinson's disease (PD) is limited. Using a prospectively collected clinical database, we studied the longitudinal trend of mini‐mental state examination (MMSE) change and baselin

Neuropsychological correlates of theory
✍ Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Domenico Errico; Marianna A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract The theory of mind is the ability to attribute mental states to oneself and others and to understand that others have beliefs, desires and intentions different from one's own. The aim of the study was to explore the neuropsychological correlates of theory of mind in patients affected by

GCH1 in early-onset Parkinson's disease
✍ Stephanie A. Cobb; Christian Wider; Owen A. Ross; Ignacio F. Mata; Charles H. Ad 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

## Abstract Mutations in __GTP‐cyclohydrolase 1__ (__GCH1__) cause autosomal dominant dopa‐responsive dystonia (DRD), characterized by childhood‐onset foot dystonia that later generalizes. DRD patients frequently present with associated Parkinsonism. Conversely, early‐onset Parkinson's disease (EOP